Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiyuki Soeda

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Molecular Neuroscience|December 21, 2020
New Insights Into Drug Discovery Targeting Tau ProteinYoshiyuki Soeda, Akihiko Takashima
Rinsho Shinkeigaku = Clinical Neurology|February 13, 2015
[Development of disease modifying drugs for dementia-focusing on anti-tau drugs-]Yoshiyuki Soeda, Akihiko Takashima
Frontiers in Aging Neuroscience|December 12, 2019
Enhanced Tau Protein Translation by Hyper-ExcitationShunsuke Kobayashi, Toru Tanaka, Yoshiyuki Soeda, et al.
Aging Brain|March 13, 2023
Memory formation in old age requires GSK-3βRiki Koike, Yuta Takaichi, Yoshiyuki Soeda, et al.
Frontiers in Neuroscience|March 17, 2018
Tau Depletion in APP Transgenic Mice Attenuates Task-Related Hyperactivation of the Hippocampus and Differentially Influences Locomotor Activity and Spatial MemoryMisato Yoshikawa, Yoshiyuki Soeda, Makoto Michikawa, et al.
Structure (London, England : 1993)|July 20, 2024
Intracellular tau fragment droplets serve as seeds for tau fibrilsYoshiyuki Soeda, Hideaki Yoshimura, Hiroko Bannai, et al.
Ebiomedicine|June 2, 2017
Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor StimulationShunsuke Kobayashi, Toru Tanaka, Yoshiyuki Soeda, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2019
Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer's DiseaseYoshiyuki Soeda, Marino Saito, Sumihiro Maeda, et al.
Journal of Neurochemistry|July 3, 2015
Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tauCe Xie, Yoshiyuki Soeda, Yuki Shinzaki, et al.
The Journal of Biological Chemistry|September 8, 2016
Modification of Tau by 8-Nitroguanosine 3',5'-Cyclic Monophosphate (8-Nitro-cGMP): EFFECTS OF NITRIC OXIDE-LINKED CHEMICAL MODIFICATION ON TAU AGGREGATIONJun Yoshitake, Yoshiyuki Soeda, Tomoaki Ida, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Molecular Neuroscience|December 21, 2020
New Insights Into Drug Discovery Targeting Tau ProteinYoshiyuki Soeda, Akihiko Takashima
Rinsho Shinkeigaku = Clinical Neurology|February 13, 2015
[Development of disease modifying drugs for dementia-focusing on anti-tau drugs-]Yoshiyuki Soeda, Akihiko Takashima
Frontiers in Aging Neuroscience|December 12, 2019
Enhanced Tau Protein Translation by Hyper-ExcitationShunsuke Kobayashi, Toru Tanaka, Yoshiyuki Soeda, et al.
Aging Brain|March 13, 2023
Memory formation in old age requires GSK-3βRiki Koike, Yuta Takaichi, Yoshiyuki Soeda, et al.
Frontiers in Neuroscience|March 17, 2018
Tau Depletion in APP Transgenic Mice Attenuates Task-Related Hyperactivation of the Hippocampus and Differentially Influences Locomotor Activity and Spatial MemoryMisato Yoshikawa, Yoshiyuki Soeda, Makoto Michikawa, et al.
Structure (London, England : 1993)|July 20, 2024
Intracellular tau fragment droplets serve as seeds for tau fibrilsYoshiyuki Soeda, Hideaki Yoshimura, Hiroko Bannai, et al.
Ebiomedicine|June 2, 2017
Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor StimulationShunsuke Kobayashi, Toru Tanaka, Yoshiyuki Soeda, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2019
Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer's DiseaseYoshiyuki Soeda, Marino Saito, Sumihiro Maeda, et al.
Journal of Neurochemistry|July 3, 2015
Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tauCe Xie, Yoshiyuki Soeda, Yuki Shinzaki, et al.
The Journal of Biological Chemistry|September 8, 2016
Modification of Tau by 8-Nitroguanosine 3',5'-Cyclic Monophosphate (8-Nitro-cGMP): EFFECTS OF NITRIC OXIDE-LINKED CHEMICAL MODIFICATION ON TAU AGGREGATIONJun Yoshitake, Yoshiyuki Soeda, Tomoaki Ida, et al.
Pageof 3